Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass.
Vertrees, R A
Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass. [electronic resource] - ASAIO journal (American Society for Artificial Internal Organs : 1992) - M554-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1058-2916
10.1097/00002480-199407000-00060 doi
Animals
Antibodies, Monoclonal--pharmacology
Cardiopulmonary Bypass--adverse effects
Leukocyte Count
Leukocytes--cytology
Leukocytes, Mononuclear--cytology
Leukocytosis--etiology
Leukopenia--etiology
Neutrophils--cytology
Swine
Time Factors
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass. [electronic resource] - ASAIO journal (American Society for Artificial Internal Organs : 1992) - M554-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1058-2916
10.1097/00002480-199407000-00060 doi
Animals
Antibodies, Monoclonal--pharmacology
Cardiopulmonary Bypass--adverse effects
Leukocyte Count
Leukocytes--cytology
Leukocytes, Mononuclear--cytology
Leukocytosis--etiology
Leukopenia--etiology
Neutrophils--cytology
Swine
Time Factors
Tumor Necrosis Factor-alpha--antagonists & inhibitors